SMN 0.00% 57.0¢ structural monitoring systems plc

Past Life

  1. 136 Posts.
    lightbulb Created with Sketch. 107
    Hi All,
    I must have done something wrong in a past life, but the current experience with SMN is very reminiscent to past experience with Cellestis.

    Cellestis had a new test for TB, and had to jump through the FDA regulatory hurdles.
    The process took about 10 years, but was ultimately granted & to things were looking good.
    Some concerns were raised about patent life & the company was taken over by a foreign concern.
    Last time I looked, the TB test was turning over $100m+ (sour grapes - you bet!)

    Not saying SMN will ultimately be the same, but when dealing with Regulator & intrenched practices, the wheels turn slowly.
    I don’t think there is an underlying conspiracy to hold Australian companies back, or delay until patents expire or because of the activities of past management.
    I suspect no one wants to fast track & then have an incident of any description on their record/conscience.
    Yes, the road is long, with many a winding turn, and while there are no guarantees in life, I’m personally not losing sleep & appreciate the updated (forecast) timetable.

    Cheers
    DrDazmo

 
watchlist Created with Sketch. Add SMN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.